Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pharmacol Exp Ther ; 304(3): 1055-62, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12604682

RESUMO

We investigated the role that prostaglandins (PGs) and EP receptors play in facilitating the gastroprotective action of capsaicin against HCl/ethanol in rats and mice. Male Sprague-Dawley rats and C57BL/6 mice were used after 18 h of fasting. The animals were given HCl/ethanol (60% in 150 mM HCl) p.o. and killed 1 h later. Capsaicin or various EP agonists were given p.o. 30 min or i.v. 10 min before HCl/ethanol. In some cases, indomethacin or various EP agonists were given s.c. 30 min or i.v 10 min before capsaicin, respectively. Gastric lesions induced by HCl/ethanol were significantly inhibited by PGE(2) as well as capsaicin. The effect of PGE(2) was antagonized by ONO-AE-829 (EP1 antagonist), whereas the capsaicin action was mitigated by indomethacin as well as sensory deafferentation but not by ONO-AE-829. The generation of mucosal PGE(2) was not affected by either capsaicin or sensory deafferentation, but was significantly inhibited by indomethacin. Although neither butaprost (EP2), ONO-NT-012 (EP3), nor 11-deoxy PGE1 (EP4) alone had any effect on HCl/ethanol-induced gastric lesions, only butaprost restored the protective action of capsaicin in the presence of indomethacin. Capsaicin provided a protective action against HCl/ethanol-induced gastric lesions in wild-type (+/+) mice in an indomethacin-sensitive manner, and this action was similarly observed in EP1 (-/-) and EP3 (-/-) mice but not in the animals lacking IP receptors. These results suggest that capsaicin exhibits gastric cytoprotection, essentially by stimulating sensory neurons, and this action is facilitated by endogenous PGs through EP2/IP receptors, probably sensitizing the sensory neurons to capsaicin.


Assuntos
Capsaicina/uso terapêutico , Epoprostenol/análogos & derivados , Prostaglandinas/metabolismo , Substâncias Protetoras/uso terapêutico , Receptores de Prostaglandina E/metabolismo , Gastropatias/prevenção & controle , 6-Cetoprostaglandina F1 alfa/metabolismo , Animais , Anti-Inflamatórios não Esteroides/farmacologia , Citoproteção/efeitos dos fármacos , Sistema Digestório/efeitos dos fármacos , Sistema Digestório/lesões , Epoprostenol/farmacologia , Etanol , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/fisiologia , Ácido Clorídrico , Indometacina/farmacologia , Masculino , Camundongos , Camundongos Knockout , Ratos , Ratos Sprague-Dawley , Receptores de Epoprostenol , Receptores de Prostaglandina/genética , Receptores de Prostaglandina/metabolismo , Receptores de Prostaglandina E/genética , Receptores de Prostaglandina E Subtipo EP2 , Fluxo Sanguíneo Regional/efeitos dos fármacos , Gastropatias/induzido quimicamente , Gastropatias/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA